Related references
Note: Only part of the references are listed.Nanoparticle uptake: The phagocyte problem
Heather Herd Gustafson et al.
NANO TODAY (2015)
Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice
Yoshinori Kato et al.
PHARMACEUTICAL RESEARCH (2015)
Magnetic Resonance Imaging Repercussions of Intravenous Iron Products Used for Iron-Deficiency Anemia and Dialysis-Associated Anemia
Guy Rostoker et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2014)
Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid
Li Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: Insights into the potential of various iron therapies to induce oxidative and nitrosative stress
Taija S. Koskenkorva-Frank et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Renal clearable inorganic nanoparticles: a new frontier of bionanotechnology
Jinbin Liu et al.
MATERIALS TODAY (2013)
Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking
Xiaopin Duan et al.
SMALL (2013)
Biodistribution and predictive hepatic gene expression of intravenous iron sucrose
Peter Elford et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2013)
Paradoxical glomerular filtration of carbon nanotubes
Alessandro Ruggiero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effect of liposome characteristics and dose on the pharmacokinetics of liposomes coated with poly(amino acid)s
Birgit Romberg et al.
PHARMACEUTICAL RESEARCH (2007)
A method to assess 59Fe in residual tissue blood content in mice and its use to correct 59Fe-distribution kinetics accordingly
Klaus Schuemann et al.
TOXICOLOGY (2007)
Renal clearance of quantum dots
Hak Soo Choi et al.
NATURE BIOTECHNOLOGY (2007)
Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients
Daniela Schiesser et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Acute injury with intravenous iron and concerns regarding long-term safety
Kalkidan Bishu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Update on adverse drug events associated with parenteral iron
GM Chertow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease -: A randomized, controlled, open-label, multicenter study
O Schröder et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
JC Wood et al.
BLOOD (2005)
Non-invasive assessment of hepatic iron stores by MRI
Y Gandon et al.
LANCET (2004)
Advances in functional and structural MR image analysis and implementation as FSL
SM Smith et al.
NEUROIMAGE (2004)
Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations
DS Kudasheva et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease
R Agarwal et al.
KIDNEY INTERNATIONAL (2004)
Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography
S Beshara et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Relaxation effects of clustered particles
A Tanimoto et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2001)
Share Paper
